Zacks Research cut shares of electroCore (NASDAQ:ECOR – Free Report) from a hold rating to a strong sell rating in a research note published on Wednesday morning,Zacks.com reports. Weiss Ratings reissued a “sell (d-)” rating on shares of electroCore in a research report on Monday, December 29th. Wall Street Zen upgraded shares of electroCore from a “sell” rating to a “hold” rating in a research note on Saturday, November 8th. Two research analysts have rated the stock with a Buy rating and two have given a Sell rating to the company’s stock. electroCore Company Profile(Get Free Report)electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey.